The Effect Of Atorvastatin On the Success Rate Of IVF In Infertile Women With Polycystic Ovarian Syndrome

The Effect Of Atorvastatin On The Success Rate of IVF In Infertile Women With Polycystic Ovarian Syndrome

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231126060191N1

Enrollment

Registered

2024-05-08

Start date

2024-05-21

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: The intervention group will be treated with metformin 500 mg TDS and atorvastatin 20 mg daily. Intervention 2: The control group will be treated with metformin 500 mg TDS.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age:18-24 BMI : 20-35 Infertility caused by PCO

Exclusion criteria

Exclusion criteria: Endometriosis Improper endometrium during the transition cycle (presence of polyps or thin endometrium Male infertility factor Uterine submucosa myomas

Design outcomes

Primary

Measure	Time frame
Pregnancy BY IVF. Timepoint: 2 months. Method of measurement: Blood sampling.	—

Secondary

Measure	Time frame
IVF SUCCESSFULITY. Timepoint: 2 Months. Method of measurement: blood.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Asadi

Kashan University of Medical Sciences

minaasadi717@gmail.com+98 31 5434 7151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026